{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:41:43Z","timestamp":1764603703527,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00415-020-10206-w","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T14:03:02Z","timestamp":1599228182000},"page":"613-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does pallidal neuromodulation influence cognitive decline in Huntington\u2019s disease?"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-5279","authenticated-orcid":false,"given":"Emily","family":"Sanrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Macioce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Cyprien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Chan Seng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Coubes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetan","family":"Poulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"10206_CR1","doi-asserted-by":"crossref","first-page":"E383","DOI":"10.1227\/01.NEU.0000195068.19801.18","volume":"58","author":"MO Hebb","year":"2006","unstructured":"Hebb MO, Garcia R, Gaudet P, Mendez IM (2006) Bilateral stimulation of the globus pallidus internus to treat choreathetosis in Huntington's disease: technical case report. Neurosurgery 58:E383 (discussion E383)","journal-title":"Neurosurgery"},{"key":"10206_CR2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ana.20183","volume":"56","author":"E Moro","year":"2004","unstructured":"Moro E, Lang AE, Strafella AP, Poon YY, Arango PM, Dagher A, Hutchison WD, Lozano AM (2004) Bilateral globus pallidus stimulation for Huntington's disease. Ann Neurol 56:290\u2013294","journal-title":"Ann Neurol"},{"key":"10206_CR3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/mds.24959","volume":"27","author":"S Spielberger","year":"2012","unstructured":"Spielberger S, Hotter A, Wolf E, Eisner W, M\u00fcller J, Poewe W, Seppi K (2012) Deep brain stimulation in Huntington's disease: A 4-year follow-up case report. Mov Disord 27:806\u2013807 (author reply 807-808)","journal-title":"Mov Disord"},{"key":"10206_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000341070","volume":"91","author":"FM Velez-Lago","year":"2013","unstructured":"Velez-Lago FM, Thompson A, Oyama G, Hardwick A, Sporrer JM, Zeilman P, Foote KD, Bowers D, Ward HE, Sanchez-Ramos J, Okun MS (2013) Differential and better response to deep brain stimulation of chorea compared to dystonia in Huntington's disease. Stereotact Funct Neurosurg 91:129\u2013133","journal-title":"Stereotact Funct Neurosurg"},{"key":"10206_CR5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1073858415581986","volume":"22","author":"S Chiken","year":"2016","unstructured":"Chiken S, Nambu A (2016) Mechanism of deep brain stimulation: inhibition, excitation, or disruption? Neuroscientist 22:313\u2013322","journal-title":"Neuroscientist"},{"key":"10206_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3171\/JNS\/2008\/109\/7\/0130","volume":"109","author":"B Biolsi","year":"2008","unstructured":"Biolsi B, Cif L, Fertit HE, Robles SG, Coubes P (2008) Long-term follow-up of Huntington disease treated by bilateral deep brain stimulation of the internal globus pallidus. J Neurosurg 109:130\u2013132","journal-title":"J Neurosurg"},{"key":"10206_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1355617701711046","volume":"7","author":"J Snowden","year":"2001","unstructured":"Snowden J, Craufurd D, Griffiths H, Thompson J, Neary D (2001) Longitudinal evaluation of cognitive disorder in Huntington's disease. J Int Neuropsychol Soc 7:33\u201344","journal-title":"J Int Neuropsychol Soc"},{"key":"10206_CR8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout JC, Jones R, Labuschagne I, O'Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, D\u00fcrr A, Leavitt BR, Roos RA, Langbehn DR, Tabrizi SJ, Frost C (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. J Neurol Neurosurg Psychiatry 83:687\u2013694","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10206_CR9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637\u2013649","journal-title":"Lancet Neurol"},{"key":"10206_CR10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/01.WNL.0000098878.47789.BD","volume":"61","author":"AK Ho","year":"2003","unstructured":"Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, An\u00e9 MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T (2003) Profile of cognitive progression in early Huntington's disease. Neurology 61:1702\u20131706","journal-title":"Neurology"},{"key":"10206_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnsys.2015.00032","volume":"9","author":"SJ Nagel","year":"2015","unstructured":"Nagel SJ, Machado AG, Gale JT, Lobel DA, Pandya M (2015) Preserving cortico-striatal function: deep brain stimulation in Huntington's disease. Front Syst Neurosci 9:32","journal-title":"Front Syst Neurosci"},{"key":"10206_CR12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jocn.2014.11.008","volume":"22","author":"M Sharma","year":"2015","unstructured":"Sharma M, Deogaonkar M (2015) Deep brain stimulation in Huntington's disease: assessment of potential targets. J Clin Neurosci 22:812\u2013817","journal-title":"J Clin Neurosci"},{"key":"10206_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson I, Fahn S (1979) Huntington disease: clinical care and evaluation. Neurology 29:1\u20133","journal-title":"Neurology"},{"key":"10206_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000068962","volume":"78","author":"P Coubes","year":"2002","unstructured":"Coubes P, Vayssiere N, El Fertit H, Hemm S, Cif L, Kienlen J, Bonafe A, Frerebeau P (2002) Deep brain stimulation for dystonia. Surg Tech Stereotact Funct Neurosurg 78:183\u2013191","journal-title":"Surg Tech Stereotact Funct Neurosurg"},{"key":"10206_CR15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"10206_CR16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.56.8.1052","volume":"56","author":"AC Bachoud-Levi","year":"2001","unstructured":"Bachoud-Levi AC, Maison P, Bartolomeo P, Boisse MF, Dalla Barba G, Ergis AM, Baudic S, Degos JD, Cesaro P, Peschanski M (2001) Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 56:1052\u20131058","journal-title":"Neurology"},{"key":"10206_CR17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/13854046.2013.825010","volume":"27","author":"M Lavoie","year":"2013","unstructured":"Lavoie M, Callahan B, Belleville S, Simard M, Bier N, Gagnon L, Gagnon JF, Blanchet S, Potvin O, Hudon C, Macoir J (2013) Normative data for the Dementia Rating Scale-2 in the French\u2013Quebec population. Clin Neuropsychol 27:1150\u20131166","journal-title":"Clin Neuropsychol"},{"key":"10206_CR18","doi-asserted-by":"crossref","unstructured":"Wechsler D (2008) Wechsler adult intelligence Scale, 4th edn (WAIS IV). Pearson","DOI":"10.1037\/t15169-000"},{"key":"10206_CR19","unstructured":"Van der Linden M, Coyette F, Pointrenaud J, Kalafat M, Calicis F, Wyns C, Adam S, et les membres du GREMEM (2004) L'\u00e9preuve de rappel libre\/rappel indice \u00e0 16 items (RL\/RI16). In: Solal (ed) L'\u00e9valuation des troubles de la m\u00e9moire. Marseille, pp 25\u201347"},{"key":"10206_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","volume":"19","author":"TN Tombaugh","year":"2004","unstructured":"Tombaugh TN (2004) Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 19:203\u2013214","journal-title":"Arch Clin Neuropsychol"},{"key":"10206_CR21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/brln.1996.0013","volume":"52","author":"D Cardebat","year":"1996","unstructured":"Cardebat D, Demonet JF, Viallard G, Faure S, Puel M, Celsis P (1996) Brain functional profiles in formal and semantic fluency tasks: a SPECT study in normals. Brain Lang 52:305\u2013313","journal-title":"Brain Lang"},{"key":"10206_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mds.27227","volume":"33","author":"TA Mestre","year":"2018","unstructured":"Mestre TA, Bachoud-L\u00e9vi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P (2018) Rating scales for cognition in Huntington's disease: critique and recommendations. Mov Disord 33:187\u2013195","journal-title":"Mov Disord"},{"key":"10206_CR23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","volume":"25","author":"GM Peavy","year":"2010","unstructured":"Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J (2010) Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord 25:1163\u20131169","journal-title":"Mov Disord"},{"key":"10206_CR24","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/mds.22173","volume":"23","author":"G Llebaria","year":"2008","unstructured":"Llebaria G, Pagonabarraga J, Kulisevsky J, Garcia-Sanchez C, Pascual-Sedano B, Gironell A, Martinez-Corral M (2008) Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord 23:1546\u20131550","journal-title":"Mov Disord"},{"key":"10206_CR25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41:689\u2013692","journal-title":"Ann Neurol"},{"key":"10206_CR26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/brainsci6030038","volume":"6","author":"L Wojtecki","year":"2016","unstructured":"Wojtecki L, Groiss SJ, Hartmann CJ, Elben S, Omlor S, Schnitzler A, Vesper J (2016) Deep brain stimulation in huntington's disease-preliminary evidence on pathophysiology efficacy and safety. Brain Sci 6:38","journal-title":"Brain Sci"},{"key":"10206_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3171\/2014.2.JNS131722","volume":"121","author":"V Gonzalez","year":"2014","unstructured":"Gonzalez V, Cif L, Biolsi B, Garcia-Ptacek S, Seychelles A, Sanrey E, Descours I, Coubes C, de Moura AM, Corlobe A, James S, Roujeau T, Coubes P (2014) Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study. J Neurosurg 121:114\u2013122","journal-title":"J Neurosurg"},{"key":"10206_CR28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/mds.22116","volume":"23","author":"A Fasano","year":"2008","unstructured":"Fasano A, Mazzone P, Piano C, Quaranta D, Soleti F, Bentivoglio AR (2008) GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case. Mov Disord 23:1289\u20131292","journal-title":"Mov Disord"},{"key":"10206_CR29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2009.202903","volume":"82","author":"GA Kang","year":"2011","unstructured":"Kang GA, Heath S, Rothlind J, Starr PA (2011) Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease. J Neurol Neurosurg Psychiatry 82:272\u2013277","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10206_CR30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.parkreldis.2018.02.030","volume":"51","author":"S Zittel","year":"2018","unstructured":"Zittel S, Tadic V, Moll CKE, B\u00e4umer T, Fellbrich A, Gulberti A, Rasche D, Br\u00fcggemann N, Tronnier V, M\u00fcnchau A (2018) Prospective evaluation of Globus pallidus internus deep brain stimulation in Huntington's disease. Parkinsonism Relat Disord 51:96\u2013100","journal-title":"Parkinsonism Relat Disord"},{"key":"10206_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fneur.2015.00177","volume":"6","author":"L Wojtecki","year":"2015","unstructured":"Wojtecki L, Groiss SJ, Ferrea S, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, S\u00fcdmeyer M, Ohmann C, Schnitzler A, Vesper J (2015) A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease. Front Neurol 6:177","journal-title":"Front Neurol"},{"key":"10206_CR32","doi-asserted-by":"crossref","unstructured":"Gruber D, Kuhn AA, Schoenecker T, Kopp UA, Kivi A, Huebl J, Lobsien E, Mueller B, Schneider GH, Kupsch A (2014) Quadruple deep brain stimulation in Huntington's disease, targeting pallidum and subthalamic nucleus: case report and review of the literature. J Neural Transm (Vienna, Austria 1996) 121:1303\u20131312","DOI":"10.1007\/s00702-014-1201-7"},{"key":"10206_CR33","doi-asserted-by":"publisher","DOI":"10.4172\/2168-975X.1000136","author":"G Loutfi","year":"2014","unstructured":"Loutfi G, Linder J, Hariz G-M, Hariz M, Blomstedt P (2014) Pallidal deep brain stimulation in the treatment of Huntington's chorea. Brain Disord Therapy. https:\/\/doi.org\/10.4172\/2168-975X.1000136","journal-title":"Brain Disord Therapy"},{"key":"10206_CR34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2013.11.007","volume":"20","author":"JL L\u00f3pez-Send\u00f3n Moreno","year":"2014","unstructured":"L\u00f3pez-Send\u00f3n Moreno JL, Garc\u00eda-Caldentey J, Regidor I, del \u00c1lamo M, Garc\u00eda de Y\u00e9benes J (2014) A 5-year follow-up of deep brain stimulation in Huntington's disease. Parkinsonism Relat Disord 20:260\u2013261","journal-title":"Parkinsonism Relat Disord"},{"key":"10206_CR35","doi-asserted-by":"crossref","unstructured":"Mason SL, Wijeyekoon R, Swain R, Ho AK, Smith EL, Sahakian B, Barker RA (2010) Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year period. PLoS Curr 2:RRN1174","DOI":"10.1371\/currents.RRN1174"},{"key":"10206_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1037\/0012-1649.40.5.813","volume":"40","author":"TA Salthouse","year":"2004","unstructured":"Salthouse TA, Schroeder DH, Ferrer E (2004) Estimating retest effects in longitudinal assessments of cognitive functioning in adults between 18 and 60 years of age. Dev Psychol 40:813\u2013822","journal-title":"Dev Psychol"},{"key":"10206_CR37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/mds.25964","volume":"29","author":"JC Stout","year":"2014","unstructured":"Stout JC, Queller S, Baker KN, Cowlishaw S, Sampaio C, Fitzer-Attas C, Borowsky B (2014) HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3. Mov Disord 29:1281\u20131288","journal-title":"Mov Disord"},{"key":"10206_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneumeth.2015.12.007","volume":"265","author":"JC Stout","year":"2016","unstructured":"Stout JC, Glikmann-Johnston Y, Andrews SC (2016) Cognitive assessment strategies in Huntington's disease research. J Neurosci Methods 265:19\u201324","journal-title":"J Neurosci Methods"},{"key":"10206_CR39","doi-asserted-by":"crossref","first-page":"e0145842","DOI":"10.1371\/journal.pone.0145842","volume":"10","author":"C Schramm","year":"2015","unstructured":"Schramm C, Katsahian S, Youssov K, D\u00e9monet JF, Krystkowiak P, Supiot F, Verny C, Cleret de Langavant L, Bachoud-L\u00e9vi AC (2015) How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease. PLoS ONE 10:e0145842","journal-title":"PLoS ONE"},{"key":"10206_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3233\/JHD-150159","volume":"4","author":"LJ Beglinger","year":"2015","unstructured":"Beglinger LJ, Adams WH, Fiedorowicz JG, Duff K, Langbehn D, Biglan K, Caviness J, Olson B, Paulsen JS (2015) Practice effects and stability of neuropsychological and UHDRS tests over short retest intervals in Huntington Disease. J Huntington's Dis 4:251\u2013260","journal-title":"J Huntington's Dis"},{"key":"10206_CR41","doi-asserted-by":"crossref","first-page":"116523","DOI":"10.1016\/j.jns.2019.116523","volume":"408","author":"P Julayanont","year":"2020","unstructured":"Julayanont P, McFarland NR, Heilman KM (2020) Mild cognitive impairment and dementia in motor manifest Huntington's disease: classification and prevalence. J Neurol Sci 408:116523","journal-title":"J Neurol Sci"},{"key":"10206_CR42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JHD-170247","volume":"6","author":"SS Chaganti","year":"2017","unstructured":"Chaganti SS, McCusker EA, Loy CT (2017) What do we know about Late Onset Huntington's Disease? J Huntington's Dis 6:95\u2013103","journal-title":"J Huntington's Dis"},{"key":"10206_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cortex.2017.07.017","volume":"95","author":"V Baake","year":"2017","unstructured":"Baake V, Reijntjes R, Dumas EM, Thompson JC, Roos RAC (2017) Cognitive decline in Huntington's disease expansion gene carriers. Cortex 95:51\u201362","journal-title":"Cortex"},{"key":"10206_CR44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","volume":"66","author":"Huntington Study G","year":"2006","unstructured":"Huntington Study G (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66:366\u2013372","journal-title":"Neurology"},{"key":"10206_CR45","doi-asserted-by":"crossref","unstructured":"Tedroff J, Waters S, Barker RA, Roos R, Squitieri F, Group ERS (2015) Antidopaminergic medication is associated with more rapidly progressive Huntington's Disease. J Huntington's Dis 4:131\u2013140","DOI":"10.3233\/JHD-150143"},{"key":"10206_CR46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/14737175.2016.1226134","volume":"17","author":"E Unti","year":"2017","unstructured":"Unti E, Mazzucchi S, Palermo G, Bonuccelli U, Ceravolo R (2017) Antipsychotic drugs in Huntington's disease. Expert Rev Neurother 17:227\u2013237","journal-title":"Expert Rev Neurother"},{"key":"10206_CR47","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/mds.25422","volume":"28","author":"EP Hart","year":"2013","unstructured":"Hart EP, Marinus J, Burgunder JM, Bentivoglio AR, Craufurd D, Reilmann R, Saft C, Roos RA (2013) Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease. Mov Disord 28:1142\u20131145","journal-title":"Mov Disord"},{"key":"10206_CR48","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1007\/s00415-016-8233-x","volume":"263","author":"M Jacobs","year":"2016","unstructured":"Jacobs M, Hart EP, van Zwet EW, Bentivoglio AR, Burgunder JM, Craufurd D, Reilmann R, Saft C, Roos RA (2016) Progression of motor subtypes in Huntington's disease: a 6-year follow-up study. J Neurol 263:2080\u20132085","journal-title":"J Neurol"},{"key":"10206_CR49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mds.25806","volume":"29","author":"EP Hart","year":"2014","unstructured":"Hart EP, Dumas EM, Schoonderbeek A, Wolthuis SC, van Zwet EW, Roos RA (2014) Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease. Mov Disord 29:320\u2013326","journal-title":"Mov Disord"},{"key":"10206_CR50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JHD-130059","volume":"2","author":"EP Hart","year":"2013","unstructured":"Hart EP, Dumas EM, Giltay EJ, Middelkoop HA, Roos RA (2013) Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years. J Huntington's Dis 2:137\u2013147","journal-title":"J Huntington's Dis"},{"key":"10206_CR51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1359105312438109","volume":"18","author":"NE Carlozzi","year":"2013","unstructured":"Carlozzi NE, Tulsky DS (2013) Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J Health Psychol 18:212\u2013225","journal-title":"J Health Psychol"},{"key":"10206_CR52","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mds.22412","volume":"24","author":"AK Ho","year":"2009","unstructured":"Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA (2009) Health-related quality of life in Huntington's disease: which factors matter most? Mov Disord 24:574\u2013578","journal-title":"Mov Disord"},{"key":"10206_CR53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00415-015-7968-0","volume":"263","author":"C Delorme","year":"2016","unstructured":"Delorme C, Rogers A, Lau B, Francisque H, Welter ML, Vidal SF, Yelnik J, Durr A, Grabli D, Karachi C (2016) Deep brain stimulation of the internal pallidum in Huntington's disease patients: clinical outcome and neuronal firing patterns. J Neurol 263:290\u2013298","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10206-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:49:11Z","timestamp":1630720151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10206"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10206-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the local ethic committee (IRB).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent was obtained from the patients and\/or legal representative for participating in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Data will be available upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}